Phenyl-imidazolyl-fatty acid derivatives
    91.
    发明授权
    Phenyl-imidazolyl-fatty acid derivatives 失效
    苯基 - 咪唑基 - 脂肪酸衍生物

    公开(公告)号:US3978069A

    公开(公告)日:1976-08-31

    申请号:US283327

    申请日:1972-08-24

    摘要: Phenyl-imidazolyl-fatty acid derivatives of the formula ##EQU1## wherein R.sup.1, R.sup.2, and R.sup.3 are the same or different, and are hydrogen or lower alkyl;R.sup.4 is hydrogen, alkyl, lower alkoxy, alkylmercapto, or an electro negative moiety;R.sup.5 is benzene, benzene substituted by alkyl, lower alkoxy, alkylmercapto or an electro negative moiety, or R.sup.5 is an aliphatic moiety;X is a carboxyl moiety or a grouping of a functional carboxylic acid derivative;m is 0, 1, 2, 3, 4, 5 or 6; andn is 0, 1 or 2,And pharmaceutically acceptable non-toxic salts thereof.These phenyl-imidazolyl-fatty acid derivatives exhibit antimycotic activity.

    摘要翻译: 式R 3 -C C的苯基 - 咪唑基 - 脂肪酸衍生物 - N并行对映R1-CC-R2 ANGLE N | -C-(CH2)mX | R5其中R1,R2和R3相同或不同,以及 是氢或低级烷基; R4是氢,烷基,低级烷氧基,烷基巯基或电负性部分; R5是苯,被烷基,低级烷氧基,烷基巯基或电负性部分取代的苯,或R5是脂族部分; X是羧基部分或官能羧酸衍生物的一组; M IS 0,1,2,3,4,5 OR 6; 和N是0,1或2,以及药物可接受的非毒性销售。

    Diaryl-pyridyl-imidazole methanes for treating mycotic infections
    92.
    发明授权
    Diaryl-pyridyl-imidazole methanes for treating mycotic infections 失效
    用于治疗真菌感染的二芳基 - 吡啶基 - 咪唑甲烷

    公开(公告)号:US3969522A

    公开(公告)日:1976-07-13

    申请号:US557354

    申请日:1975-03-11

    IPC分类号: A61K31/44

    CPC分类号: A61K31/44

    摘要: Diaryl-pyridyl-imidazolyl methanes of the formula ##SPC1##And pharmaceutically acceptable non-toxic salts thereof, wherein R.sup.1 and R.sup.2 are the same or different alkyl of 1 to 4 carbon atoms, are produced either byA. reacting a (dialkylphenyl-phenyl-pyridyl)-methanol of the formula ##SPC2##Wherein R.sup.1 and R.sup.2 are as above defined, with thionyl-bis-imidazole in the presence of an inert organic diluent at a temperature of from -20.degree. C to about 150.degree. C; orB. reacting a (dialkylphenyl-phenyl-pyridyl)-methyl halide of the formula ##SPC3##Wherein R.sup.1 and R.sup.2 are as above defined and Hal is chlorine or bromine, with imidazole in the presence of an acid binding agent at a temperature of from 20.degree. C to about 180.degree.C. The diaryl-pyridyl-imidazole methanes of the present invention are useful for their antimycotic activity.

    摘要翻译: 式II的二芳基 - 吡啶基 - 咪唑基甲烷及其药学上可接受的非毒性盐,其中R 1和R 2是相同或不同的1至4个碳原子的烷基,由A.产生A(对二苯基苯基 - 吡啶基) 在惰性有机稀释剂存在下,在-20℃至约150℃的温度下,在亚甲基 - 双 - 咪唑存在的情况下,R1和R2如上所定义。 或B.反应式(R 1和R 2如上所定义),并且Hal是氯或溴,在酸性粘合剂存在下,在20℃的温度下,将式(1)中的(对二苯基苯基) - 吡啶基 - 本发明的二芳基 - 吡啶基 - 咪唑甲烷可用于其抗真菌活性。

    Imidazolylacetic acid amides
    93.
    发明授权
    Imidazolylacetic acid amides 失效
    咪唑啉酸

    公开(公告)号:US3950354A

    公开(公告)日:1976-04-13

    申请号:US400263

    申请日:1973-09-24

    摘要: Imidazolylacetic acid amides of the formula: ##SPC1##Or pharmaceutically acceptable nontoxic salts thereof whereinEitherR.sup.1 is phenyl or cycloalkyl, unsubstituted or substituted by one or more substituents; andR.sup.2 is hydrogen;OrR.sup.1 and R.sup.2, together with the nitrogen atom to which they are attached, form a saturated 5 to 7-membered heterocyclic ring which ring may contain an --SO.sub.2 -- or --NY-- moiety wherein Y is alkoxycarbonyl, dialkylaminocarbonyl, or phenyl or diphenylmethyl, unsubstituted or substituted by one or more substituents and wherein said 5 to 7-membered heterocyclic ring itself is otherwise unsubstituted or substituted by one or more substituents; andX.sup.1, x.sup.2, x.sup.3 and X.sup.4 are the same or different and are each hydrogen or halogen,Are produced byA. reacting a halodiphenylacetic acid amide of the formula: ##SPC2##WhereinR.sup.1, r.sup.2, x.sup.1, x.sup.2, x.sup.3 and X.sup.4 are as above defined, andHal is halogen,With imidazole; orB. reacting a halodiphenylacetic acid halide of the formula: ##SPC3##WhereinX.sup.1, x.sup.2, x.sup.3 and X.sup.4 are as above defined andHal is halogenWith imidazole to produce an imidazolide of the formula: ##SPC4##WhereinX.sup.1, x.sup.2, x.sup.3 and X.sup.4 are as above defined which in turn is transaminated by reaction with an amine of the formula:NHR.sup.1 R.sup.2wherein R.sup.1 and R.sup.2 are as above defined.